Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/06/2024
UPDATED: 11/06/2024
DUE: 09/07/2026
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as ...
Counter-Unmanned Aircraft Systems (C-UAS) Grant Program
$250,000,000
DHS-DHS
POSTED: 11/07/2025
UPDATED: 11/07/2025
DUE: 12/05/2025
The Counter-Unmanned Aircraft Systems (C-UAS) Grant Program, established under the One Big Beautiful Bill Act, 2025 (Pub. L. No. 119-21, Sec. 90005(a)), provides $500 million in funding to enhance sta...
FIFA World Cup Grant Program (FWCGP)
$625,000,000
DHS-DHS
POSTED: 11/07/2025
UPDATED: 11/07/2025
DUE: 12/05/2025
The FIFA World Cup Grant Program (FWCGP), administered by the U.S. Department of Homeland Security (DHS) through the Federal Emergency Management Agency’s (FEMA) Grant Programs Directorate (GPD), pr...
FY24 CRS Congressionally Directed Spending-Track Intrusion System and Positive Train Control Project, CA
$1,000,000
DOT-FRA
POSTED: 11/05/2025
UPDATED: 11/05/2025
DUE: 11/14/2025
The Project will demonstrate the efficacy deploying artificial intelligence for prototype track intrusion detection, integrated with PTC, on a 4.1 mile stretch of railroad on the Ventura Subdivision t...
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/14/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue a small clinical trial to obtain critical information necessary to advance recording and/or stimulating devices to treat centra...
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 09/28/2026
The purpose of this announcement is to encourage investigators to pursue translational activities and small clinical studies to advance the development of therapeutic, and diagnostic devices for disor...
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, sc...
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
HHS-NIH11
POSTED: 11/05/2024
UPDATED: 11/05/2024
DUE: 10/25/2027
The purpose of this NOFO is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, s...
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
HHS-NIH11
POSTED: 11/04/2024
UPDATED: 11/04/2024
DUE: 10/20/2027
Reissue PAR-21-122. This NOFO provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological ac...
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
HHS-NIH11
POSTED: 11/04/2019
UPDATED: 10/12/2021
DUE: 10/12/2121
This Funding Opportunity Announcement (FOA) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-designated Cancer Centers. CCSGs support two types of cancer centers: 1) Co...